According to Latest Research, the global market for Veterinary Drug Premix should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Veterinary Drug Premix market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Veterinary Drug Premix market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Plant Breeding grew percent to account for percent of the total market sales, and Self-Employed Person grew percent.
This report studies and analyses global Veterinary Drug Premix status and future trends, helps the client to determine the Veterinary Drug Premix market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Veterinary Drug Premix, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Veterinary Drug Premix market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Veterinary Drug Premix sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Veterinary Drug Premix sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Veterinary Drug Premix key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Veterinary Drug Premix key producing regions, capacity, production, and year over year growth
(6) Veterinary Drug Premix industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bayer AG
Elanco
Zhejiang Esigma Biotechnology
Shandong Shengli Bioengineering
Jinhe Biotechnology
Shandong Luxi Animal Medicine Share
Zhengbang Group
Jiangsu Xinyu Pharmaceutical
Zhejiang Dayang Biotech Group
Zhengzhou Nongda Veterinary Medicine
China Tai Conti
Zhejiang Oulun Coating Technology
Pfizer Inc
Shandong Lukang Pharmaceutical
Zhejiang Kangmu Animal Health
Xinyu Pharmaceutical
INNER MONGOLIA Biok BIOLOGY
Market segment by Type, covers
Powder
Particles
Market segment by Application, can be divided into
Plant Breeding
Self-Employed Person
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Veterinary Drug Premix product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Veterinary Drug Premix market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Veterinary Drug Premix market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Veterinary Drug Premix, percent & CAGR, 2018-2029
Chapter 5: Veterinary Drug Premix industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Veterinary Drug Premix Definition
1.2 Global Veterinary Drug Premix Market Size and Forecast
1.2.1 By Consumption Value, Global Veterinary Drug Premix Market Size,2018-2029
1.2.2 By Sales Quantity, Global Veterinary Drug Premix Market Size,2018-2029
1.2.3 Global Veterinary Drug Premix Average Selling Price (ASP),2018-2029
1.3 China Veterinary Drug Premix Market Size and Forecast
1.3.1 By Consumption Value, China Veterinary Drug Premix Market Size,2018-2029
1.3.2 By Sales Quantity, China Veterinary Drug Premix Market Size,2018-2029
1.3.3 China Veterinary Drug Premix Average Selling Price (ASP), 2018-2029
1.4 Share of China Veterinary Drug Premix Market with Respect to the Global Market
1.4.1 By Consumption Value, China Veterinary Drug Premix Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Veterinary Drug Premix Market Share in Global, 2018-2029
1.4.3 Veterinary Drug Premix Market Size: China VS Global, 2018-2029
1.5 Veterinary Drug Premix Market Dynamics
1.5.1 Veterinary Drug Premix Market Drivers
1.5.2 Veterinary Drug Premix Market Restraints
1.5.3 Veterinary Drug Premix Industry Trends
1.5.4 Veterinary Drug Premix Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Veterinary Drug Premix, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Veterinary Drug Premix, Global Market Share by Company, 2018-2023
2.3 Veterinary Drug Premix Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Veterinary Drug Premix Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Veterinary Drug Premix Concentration Ratio
2.6 Global Veterinary Drug Premix Mergers & Acquisitions, Expansion Plans
2.7 Global Veterinary Drug Premix Manufacturers Product Type
2.8 Head Office and Veterinary Drug Premix Production Site of Key Manufacturer
2.9 Veterinary Drug Premix Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Veterinary Drug Premix, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Veterinary Drug Premix, China Market Share by Company, 2018-2023
3.3 China Veterinary Drug Premix Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Veterinary Drug Premix Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Veterinary Drug Premix Capacity by Region
4.3 Global Veterinary Drug Premix Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Veterinary Drug Premix Production by Region, 2018-2029
4.5 Global Veterinary Drug Premix Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Veterinary Drug Premix Industry Chain
5.2 Veterinary Drug Premix Upstream Analysis
5.2.1 Veterinary Drug Premix Core Raw Materials
5.2.2 Main Manufacturers of Veterinary Drug Premix Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Veterinary Drug Premix Production Mode
5.6 Veterinary Drug Premix Procurement Model
5.7 Veterinary Drug Premix Industry Sales Model and Sales Channels
5.7.1 Veterinary Drug Premix Sales Model
5.7.2 Veterinary Drug Premix Typical Distributors
6 Sights by Type
6.1 Veterinary Drug Premix Classification
6.1.1 Powder
6.1.2 Particles
6.2 By Type, Global Veterinary Drug Premix Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Veterinary Drug Premix Consumption Value, 2018-2029
6.4 By Type, Global Veterinary Drug Premix Sales Quantity, 2018-2029
6.5 By Type, Global Veterinary Drug Premix Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Veterinary Drug Premix Segment by Application
7.1.1 Plant Breeding
7.1.2 Self-Employed Person
7.2 By Application, Global Veterinary Drug Premix Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Veterinary Drug Premix Consumption Value, 2018-2029
7.4 By Application, Global Veterinary Drug Premix Sales Quantity, 2018-2029
7.5 By Application, Global Veterinary Drug Premix Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Veterinary Drug Premix Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Veterinary Drug Premix Consumption Value, 2018-2029
8.3 By Region, Global Veterinary Drug Premix Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Veterinary Drug Premix & Forecasts, 2018-2029
8.4.2 By Country, North America Veterinary Drug Premix Market Size Market Share
8.5 Europe
8.5.1 Europe Veterinary Drug Premix Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Veterinary Drug Premix Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Veterinary Drug Premix Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Veterinary Drug Premix Market Size Market Share
8.7 South America
8.7.1 South America Veterinary Drug Premix Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Veterinary Drug Premix Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Veterinary Drug Premix Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Veterinary Drug Premix Consumption Value, 2018-2029
9.3 By Country, Global Veterinary Drug Premix Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Veterinary Drug Premix Market Size, 2018-2029
9.4.2 By Type, U.S. Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Veterinary Drug Premix Market Size, 2018-2029
9.5.2 By Type, Europe Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Veterinary Drug Premix Market Size, 2018-2029
9.6.2 By Type, China Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Veterinary Drug Premix Market Size, 2018-2029
9.7.2 By Type, Japan Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Veterinary Drug Premix Market Size, 2018-2029
9.8.2 By Type, South Korea Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Veterinary Drug Premix Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Veterinary Drug Premix Market Size, 2018-2029
9.10.2 By Type, India Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Veterinary Drug Premix Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Bayer AG
10.1.1 Bayer AG Company Information, Head Office, Market Area, and Industry Position
10.1.2 Bayer AG Veterinary Drug Premix Models, Specifications, and Application
10.1.3 Bayer AG Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Bayer AG Company Profile and Main Business
10.1.5 Bayer AG Recent Developments
10.2 Elanco
10.2.1 Elanco Company Information, Head Office, Market Area, and Industry Position
10.2.2 Elanco Veterinary Drug Premix Models, Specifications, and Application
10.2.3 Elanco Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Elanco Company Profile and Main Business
10.2.5 Elanco Recent Developments
10.3 Zhejiang Esigma Biotechnology
10.3.1 Zhejiang Esigma Biotechnology Company Information, Head Office, Market Area, and Industry Position
10.3.2 Zhejiang Esigma Biotechnology Veterinary Drug Premix Models, Specifications, and Application
10.3.3 Zhejiang Esigma Biotechnology Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Zhejiang Esigma Biotechnology Company Profile and Main Business
10.3.5 Zhejiang Esigma Biotechnology Recent Developments
10.4 Shandong Shengli Bioengineering
10.4.1 Shandong Shengli Bioengineering Company Information, Head Office, Market Area, and Industry Position
10.4.2 Shandong Shengli Bioengineering Veterinary Drug Premix Models, Specifications, and Application
10.4.3 Shandong Shengli Bioengineering Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Shandong Shengli Bioengineering Company Profile and Main Business
10.4.5 Shandong Shengli Bioengineering Recent Developments
10.5 Jinhe Biotechnology
10.5.1 Jinhe Biotechnology Company Information, Head Office, Market Area, and Industry Position
10.5.2 Jinhe Biotechnology Veterinary Drug Premix Models, Specifications, and Application
10.5.3 Jinhe Biotechnology Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Jinhe Biotechnology Company Profile and Main Business
10.5.5 Jinhe Biotechnology Recent Developments
10.6 Shandong Luxi Animal Medicine Share
10.6.1 Shandong Luxi Animal Medicine Share Company Information, Head Office, Market Area, and Industry Position
10.6.2 Shandong Luxi Animal Medicine Share Veterinary Drug Premix Models, Specifications, and Application
10.6.3 Shandong Luxi Animal Medicine Share Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Shandong Luxi Animal Medicine Share Company Profile and Main Business
10.6.5 Shandong Luxi Animal Medicine Share Recent Developments
10.7 Zhengbang Group
10.7.1 Zhengbang Group Company Information, Head Office, Market Area, and Industry Position
10.7.2 Zhengbang Group Veterinary Drug Premix Models, Specifications, and Application
10.7.3 Zhengbang Group Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Zhengbang Group Company Profile and Main Business
10.7.5 Zhengbang Group Recent Developments
10.8 Jiangsu Xinyu Pharmaceutical
10.8.1 Jiangsu Xinyu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Models, Specifications, and Application
10.8.3 Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Jiangsu Xinyu Pharmaceutical Company Profile and Main Business
10.8.5 Jiangsu Xinyu Pharmaceutical Recent Developments
10.9 Zhejiang Dayang Biotech Group
10.9.1 Zhejiang Dayang Biotech Group Company Information, Head Office, Market Area, and Industry Position
10.9.2 Zhejiang Dayang Biotech Group Veterinary Drug Premix Models, Specifications, and Application
10.9.3 Zhejiang Dayang Biotech Group Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Zhejiang Dayang Biotech Group Company Profile and Main Business
10.9.5 Zhejiang Dayang Biotech Group Recent Developments
10.10 Zhengzhou Nongda Veterinary Medicine
10.10.1 Zhengzhou Nongda Veterinary Medicine Company Information, Head Office, Market Area, and Industry Position
10.10.2 Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Models, Specifications, and Application
10.10.3 Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Zhengzhou Nongda Veterinary Medicine Company Profile and Main Business
10.10.5 Zhengzhou Nongda Veterinary Medicine Recent Developments
10.11 China Tai Conti
10.11.1 China Tai Conti Company Information, Head Office, Market Area, and Industry Position
10.11.2 China Tai Conti Veterinary Drug Premix Models, Specifications, and Application
10.11.3 China Tai Conti Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 China Tai Conti Company Profile and Main Business
10.11.5 China Tai Conti Recent Developments
10.12 Zhejiang Oulun Coating Technology
10.12.1 Zhejiang Oulun Coating Technology Company Information, Head Office, Market Area, and Industry Position
10.12.2 Zhejiang Oulun Coating Technology Veterinary Drug Premix Models, Specifications, and Application
10.12.3 Zhejiang Oulun Coating Technology Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Zhejiang Oulun Coating Technology Company Profile and Main Business
10.12.5 Zhejiang Oulun Coating Technology Recent Developments
10.13 Pfizer Inc
10.13.1 Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
10.13.2 Pfizer Inc Veterinary Drug Premix Models, Specifications, and Application
10.13.3 Pfizer Inc Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Pfizer Inc Company Profile and Main Business
10.13.5 Pfizer Inc Recent Developments
10.14 Shandong Lukang Pharmaceutical
10.14.1 Shandong Lukang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Shandong Lukang Pharmaceutical Veterinary Drug Premix Models, Specifications, and Application
10.14.3 Shandong Lukang Pharmaceutical Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Shandong Lukang Pharmaceutical Company Profile and Main Business
10.14.5 Shandong Lukang Pharmaceutical Recent Developments
10.15 Zhejiang Kangmu Animal Health
10.15.1 Zhejiang Kangmu Animal Health Company Information, Head Office, Market Area, and Industry Position
10.15.2 Zhejiang Kangmu Animal Health Veterinary Drug Premix Models, Specifications, and Application
10.15.3 Zhejiang Kangmu Animal Health Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Zhejiang Kangmu Animal Health Company Profile and Main Business
10.15.5 Zhejiang Kangmu Animal Health Recent Developments
10.16 Xinyu Pharmaceutical
10.16.1 Xinyu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.16.2 Xinyu Pharmaceutical Veterinary Drug Premix Models, Specifications, and Application
10.16.3 Xinyu Pharmaceutical Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Xinyu Pharmaceutical Company Profile and Main Business
10.16.5 Xinyu Pharmaceutical Recent Developments
10.17 INNER MONGOLIA Biok BIOLOGY
10.17.1 INNER MONGOLIA Biok BIOLOGY Company Information, Head Office, Market Area, and Industry Position
10.17.2 INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Models, Specifications, and Application
10.17.3 INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 INNER MONGOLIA Biok BIOLOGY Company Profile and Main Business
10.17.5 INNER MONGOLIA Biok BIOLOGY Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Veterinary Drug Premix Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Veterinary Drug Premix Market Restraints
Table 3. Veterinary Drug Premix Market Trends
Table 4. Veterinary Drug Premix Industry Policy
Table 5. Global Veterinary Drug Premix Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Veterinary Drug Premix Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Veterinary Drug Premix Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 8. Global Veterinary Drug Premix Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Veterinary Drug Premix Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)
Table 10. Global Veterinary Drug Premix Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Veterinary Drug Premix Mergers & Acquisitions, Expansion Plans
Table 12. Global Veterinary Drug Premix Manufacturers Product Type
Table 13. Head Office and Veterinary Drug Premix Production Site of Key Manufacturer
Table 14. Veterinary Drug Premix Capacity of Major Manufacturers and Future Plan
Table 15. China Veterinary Drug Premix Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Veterinary Drug Premix Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 17. China Veterinary Drug Premix Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Veterinary Drug Premix Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 19. Global Veterinary Drug Premix Production by Region, 2018-2023, (Tons)
Table 20. Global Veterinary Drug Premix Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of Veterinary Drug Premix Upstream (Raw Materials)
Table 22. Global Veterinary Drug Premix Typical Customers
Table 23. Veterinary Drug Premix Typical Distributors
Table 24. By Type, Global Veterinary Drug Premix Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Veterinary Drug Premix Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Veterinary Drug Premix Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Veterinary Drug Premix Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Veterinary Drug Premix Sales Quantity, 2018-2029, (Tons)
Table 29. By Country, Global Veterinary Drug Premix Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Veterinary Drug Premix Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Veterinary Drug Premix Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Veterinary Drug Premix Sales Quantity, 2018-2029, (Tons)
Table 33. By Country, Global Veterinary Drug Premix Sales Quantity Market Share, 2018-2029
Table 34. Bayer AG Company Information, Head Office, Market Area, and Industry Position
Table 35. Bayer AG Veterinary Drug Premix Models, Specifications, and Application
Table 36. Bayer AG Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 37. Bayer AG Company Profile and Main Business
Table 38. Bayer AG Recent Developments
Table 39. Elanco Company Information, Head Office, Market Area, and Industry Position
Table 40. Elanco Veterinary Drug Premix Models, Specifications, and Application
Table 41. Elanco Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Elanco Company Profile and Main Business
Table 43. Elanco Recent Developments
Table 44. Zhejiang Esigma Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 45. Zhejiang Esigma Biotechnology Veterinary Drug Premix Models, Specifications, and Application
Table 46. Zhejiang Esigma Biotechnology Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Zhejiang Esigma Biotechnology Company Profile and Main Business
Table 48. Zhejiang Esigma Biotechnology Recent Developments
Table 49. Shandong Shengli Bioengineering Company Information, Head Office, Market Area, and Industry Position
Table 50. Shandong Shengli Bioengineering Veterinary Drug Premix Models, Specifications, and Application
Table 51. Shandong Shengli Bioengineering Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. Shandong Shengli Bioengineering Company Profile and Main Business
Table 53. Shandong Shengli Bioengineering Recent Developments
Table 54. Jinhe Biotechnology Company Information, Head Office, Market Area, and Industry Position
Table 55. Jinhe Biotechnology Veterinary Drug Premix Models, Specifications, and Application
Table 56. Jinhe Biotechnology Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Jinhe Biotechnology Company Profile and Main Business
Table 58. Jinhe Biotechnology Recent Developments
Table 59. Shandong Luxi Animal Medicine Share Company Information, Head Office, Market Area, and Industry Position
Table 60. Shandong Luxi Animal Medicine Share Veterinary Drug Premix Models, Specifications, and Application
Table 61. Shandong Luxi Animal Medicine Share Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. Shandong Luxi Animal Medicine Share Company Profile and Main Business
Table 63. Shandong Luxi Animal Medicine Share Recent Developments
Table 64. Zhengbang Group Company Information, Head Office, Market Area, and Industry Position
Table 65. Zhengbang Group Veterinary Drug Premix Models, Specifications, and Application
Table 66. Zhengbang Group Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Zhengbang Group Company Profile and Main Business
Table 68. Zhengbang Group Recent Developments
Table 69. Jiangsu Xinyu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Models, Specifications, and Application
Table 71. Jiangsu Xinyu Pharmaceutical Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. Jiangsu Xinyu Pharmaceutical Company Profile and Main Business
Table 73. Jiangsu Xinyu Pharmaceutical Recent Developments
Table 74. Zhejiang Dayang Biotech Group Company Information, Head Office, Market Area, and Industry Position
Table 75. Zhejiang Dayang Biotech Group Veterinary Drug Premix Models, Specifications, and Application
Table 76. Zhejiang Dayang Biotech Group Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. Zhejiang Dayang Biotech Group Company Profile and Main Business
Table 78. Zhejiang Dayang Biotech Group Recent Developments
Table 79. Zhengzhou Nongda Veterinary Medicine Company Information, Head Office, Market Area, and Industry Position
Table 80. Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Models, Specifications, and Application
Table 81. Zhengzhou Nongda Veterinary Medicine Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Zhengzhou Nongda Veterinary Medicine Company Profile and Main Business
Table 83. Zhengzhou Nongda Veterinary Medicine Recent Developments
Table 84. China Tai Conti Company Information, Head Office, Market Area, and Industry Position
Table 85. China Tai Conti Veterinary Drug Premix Models, Specifications, and Application
Table 86. China Tai Conti Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 87. China Tai Conti Company Profile and Main Business
Table 88. China Tai Conti Recent Developments
Table 89. Zhejiang Oulun Coating Technology Company Information, Head Office, Market Area, and Industry Position
Table 90. Zhejiang Oulun Coating Technology Veterinary Drug Premix Models, Specifications, and Application
Table 91. Zhejiang Oulun Coating Technology Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 92. Zhejiang Oulun Coating Technology Company Profile and Main Business
Table 93. Zhejiang Oulun Coating Technology Recent Developments
Table 94. Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
Table 95. Pfizer Inc Veterinary Drug Premix Models, Specifications, and Application
Table 96. Pfizer Inc Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 97. Pfizer Inc Company Profile and Main Business
Table 98. Pfizer Inc Recent Developments
Table 99. Shandong Lukang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 100. Shandong Lukang Pharmaceutical Veterinary Drug Premix Models, Specifications, and Application
Table 101. Shandong Lukang Pharmaceutical Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 102. Shandong Lukang Pharmaceutical Company Profile and Main Business
Table 103. Shandong Lukang Pharmaceutical Recent Developments
Table 104. Zhejiang Kangmu Animal Health Company Information, Head Office, Market Area, and Industry Position
Table 105. Zhejiang Kangmu Animal Health Veterinary Drug Premix Models, Specifications, and Application
Table 106. Zhejiang Kangmu Animal Health Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 107. Zhejiang Kangmu Animal Health Company Profile and Main Business
Table 108. Zhejiang Kangmu Animal Health Recent Developments
Table 109. Xinyu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 110. Xinyu Pharmaceutical Veterinary Drug Premix Models, Specifications, and Application
Table 111. Xinyu Pharmaceutical Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 112. Xinyu Pharmaceutical Company Profile and Main Business
Table 113. Xinyu Pharmaceutical Recent Developments
Table 114. INNER MONGOLIA Biok BIOLOGY Company Information, Head Office, Market Area, and Industry Position
Table 115. INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Models, Specifications, and Application
Table 116. INNER MONGOLIA Biok BIOLOGY Veterinary Drug Premix Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 117. INNER MONGOLIA Biok BIOLOGY Company Profile and Main Business
Table 118. INNER MONGOLIA Biok BIOLOGY Recent Developments
List of Figures
Figure 1. Veterinary Drug Premix Picture
Figure 2. Global Veterinary Drug Premix Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Veterinary Drug Premix Sales Quantity, (Tons) & (2018-2029)
Figure 4. Global Veterinary Drug Premix Average Selling Price (ASP), (2018-2029) & (US$/Ton)
Figure 5. China Veterinary Drug Premix Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Veterinary Drug Premix Sales Quantity (Tons) & (2018-2029)
Figure 7. China Veterinary Drug Premix Average Selling Price (ASP), (US$/Ton) & (2018-2029)
Figure 8. By Consumption Value, China Veterinary Drug Premix Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Veterinary Drug Premix Market Share of Global, 2018-2029
Figure 10. Global Veterinary Drug Premix Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Veterinary Drug Premix Key Participants, Market Share, 2022
Figure 12. Global Veterinary Drug Premix Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Veterinary Drug Premix Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Veterinary Drug Premix Production Market Share & Forecast by Region, 2018-2029
Figure 15. Veterinary Drug Premix Industry Chain
Figure 16. Veterinary Drug Premix Procurement Model
Figure 17. Veterinary Drug Premix Sales Model
Figure 18. Veterinary Drug Premix Sales Channels, Direct Sales, and Distribution
Figure 19. Powder
Figure 20. Particles
Figure 21. By Type, Global Veterinary Drug Premix Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Veterinary Drug Premix Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Veterinary Drug Premix Sales Quantity, 2018-2029, (Tons)
Figure 24. By Type, Global Veterinary Drug Premix Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Veterinary Drug Premix Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 26. Plant Breeding
Figure 27. Self-Employed Person
Figure 28. By Application, Global Veterinary Drug Premix Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global Veterinary Drug Premix Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global Veterinary Drug Premix Sales Quantity, 2018-2029, (Tons)
Figure 31. By Application, Global Veterinary Drug Premix Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global Veterinary Drug Premix Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 33. By Region, Global Veterinary Drug Premix Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global Veterinary Drug Premix Sales Quantity Market Share, 2018-2029
Figure 35. North America Veterinary Drug Premix Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America Veterinary Drug Premix Consumption Value Market Share, 2022
Figure 37. Europe Veterinary Drug Premix Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe Veterinary Drug Premix Consumption Value Market Share, 2022
Figure 39. Asia Pacific Veterinary Drug Premix Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific Veterinary Drug Premix Consumption Value Market Share, 2022
Figure 41. South America Veterinary Drug Premix Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America Veterinary Drug Premix Consumption Value Market Share, 2022
Figure 43. Middle East & Africa Veterinary Drug Premix Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. Veterinary Drug Premix Sales Quantity, 2018-2029, (Tons)
Figure 45. By Type, U.S. Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. Veterinary Drug Premix Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe Veterinary Drug Premix Sales Quantity, 2018-2029, (Tons)
Figure 48. By Type, Europe Veterinary Drug Premix Sal
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|